Table: Taiko Pharmaceutical - 6-MTH group results

Taiko Pharmaceutical

08/11/2019 06:00

Nov 8 (Reuters)- 
             Taiko Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   6 months ended      6 months ended       Year to 
                  Sep 30, 2019        Sep 30, 2018     Mar 31, 2020 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               4.39                3.83             11.26    
                   (+14.6 pct)         (+5.3 pct)       (+8.1 pct)  
  Operating          980 mln             644 mln            2.20    
                   (+52.3 pct)         (+28.1 pct)      (+8.4 pct)  
  Recurring          882 mln             603 mln            1.95    
                   (+46.2 pct)         (+57.7 pct)      (+3.4 pct)  
  Net                641 mln             448 mln            1.42    
                   (+43.2 pct)         (+62.3 pct)      (+0.3 pct)  
  EPS               45.19 yen           31.43 yen        99.00 yen  
  EPS Diluted       45.16 yen           31.37 yen                   
  Ann Div                               35.00 yen        30.00 yen  
  -Q2 div           10.00 yen           10.00 yen                   
  -Q4 div                               25.00 yen        20.00 yen  
  
  NOTE - Taiko Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4574.T